Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children

Lancet. 1988 Nov 19;2(8621):1182-4. doi: 10.1016/s0140-6736(88)90244-9.

Abstract

134 Gambian children under 5 years of age with severe pneumonia (as defined by the World Health Organisation classification of acute respiratory infections) were given either oral co-trimoxazole for 5 days, or a single intramuscular dose of fortified procaine penicillin and 5 days of oral ampicillin. At 2 weeks, there was no significant difference in outcome between the two groups. Co-trimoxazole is much less expensive than ampicillin or procaine penicillin, requires only twice-daily administration, and can be given by health-care staff with little training. The results support the use of co-trimoxazole as the antibiotic of first choice in outpatient management of young children with pneumonia in developing countries.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Ambulatory Care
  • Ampicillin / therapeutic use
  • Anti-Infective Agents / therapeutic use*
  • Child, Preschool
  • Clinical Trials as Topic
  • Drug Combinations / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infant
  • Male
  • Penicillin G / therapeutic use*
  • Penicillin G Procaine / therapeutic use*
  • Pneumonia / drug therapy*
  • Sulfamethoxazole / therapeutic use*
  • Trimethoprim / therapeutic use*
  • Trimethoprim, Sulfamethoxazole Drug Combination

Substances

  • Anti-Infective Agents
  • Drug Combinations
  • Penicillin G Procaine
  • Ampicillin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Trimethoprim
  • Sulfamethoxazole
  • Penicillin G